KalVista Pharmaceuticals
KALV
#6424
Rank
โ‚ฌ0.55 B
Marketcap
11,30ย โ‚ฌ
Share price
-1.61%
Change (1 day)
-0.91%
Change (1 year)

EPS for KalVista Pharmaceuticals (KALV)

EPS in 2023 (TTM): -2,96ย โ‚ฌ

According to KalVista Pharmaceuticals's latest financial reports the company's current EPS (TTM) is -2,91ย โ‚ฌ. In 2022 the company made an earnings per share (EPS) of -3,45ย โ‚ฌ a decrease over its 2021 EPS that were of -2,46ย โ‚ฌ.

EPS history for KalVista Pharmaceuticals from 2014 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-2,96ย โ‚ฌ-14.22%
2022-3,45ย โ‚ฌ40.07%
2021-2,46ย โ‚ฌ28.37%
2020-1,92ย โ‚ฌ41.5%
2019-1,36ย โ‚ฌ18.55%
2018-1,14ย โ‚ฌ-49.8%
2017-2,28ย โ‚ฌ
2015-13,94ย โ‚ฌ-6.99%
2014-14,99ย โ‚ฌ

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-2,01ย โ‚ฌ-31.01%๐Ÿ‡บ๐Ÿ‡ธ USA